XML 21 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Feb. 24, 2023
Feb. 25, 2022
Feb. 24, 2023
Feb. 25, 2022
Total net sales $ 429,174 $ 449,171 $ 894,652 $ 919,115
Total cost of sales 318,793 336,458 665,861 684,201
Gross profit 110,381 112,713 228,791 234,914
Operating expenses:        
Research and development 26,665 18,794 50,721 36,451
Selling, general and administrative 62,771 53,114 133,793 105,664
Impairment of goodwill 17,558 0 17,558 0
Change in fair value of contingent consideration 6,400 24,000 10,100 41,200
Other operating (income) expense 4,154 0 6,195 0
Total operating expenses 117,548 95,908 218,367 183,315
Operating income (loss) (7,167) 16,805 10,424 51,599
Non-operating (income) expense:        
Interest expense, net 8,006 4,462 16,043 9,568
Other non-operating (income) expense 13,329 1,785 12,669 3,020
Total non-operating (income) expense 21,335 6,247 28,712 12,588
Income (loss) before taxes (28,502) 10,558 (18,288) 39,011
Income tax provision (benefit) (1,716) 7,586 3,174 15,341
Net income (loss) (26,786) 2,972 (21,462) 23,670
Net income attributable to noncontrolling interest 433 514 765 1,185
Net income (loss) attributable to SGH $ (27,219) $ 2,458 $ (22,227) $ 22,485
Earnings (loss) per share        
Basic (in usd per share) $ (0.55) $ 0.05 $ (0.45) $ 0.46
Diluted (in usd per share) $ (0.55) $ 0.04 $ (0.45) $ 0.40
Shares used in per share calculations:        
Basic (in shares) 49,116 49,522 49,039 49,267
Diluted (in shares) 49,116 57,636 49,039 56,135
Products        
Total net sales $ 373,849 $ 413,534 $ 764,038 $ 850,218
Total cost of sales 297,134 320,827 615,794 656,251
Services        
Total net sales 55,325 35,637 130,614 68,897
Total cost of sales $ 21,659 $ 15,631 $ 50,067 $ 27,950